Nasal polyp. Other polyp of sinus
Conditions
Interventions
Intervention 1: The intervention group will receive approximately 5 cc (2.5 cc in each nasal cavity) of Orthokine after surgery. Intervention 2: The control group will receive approximately 5 cc (2.5
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Informed consent Patients between 18 and 60 years of age who have been receiving drug treatment for at least 3 months Patients diagnosed with polyposis without a history of other diseases, including tumors of the sinonasal region, etc.
Exclusion criteria
Exclusion criteria: History of underlying diseases such as immune system deficiencies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in endoscopic symptoms. Timepoint: Immediately, two and four weeks after injection. Method of measurement: Using the Lund-Kennedy scale.;Change in clinical symptoms. Timepoint: Immediately, two and four weeks after injection. Method of measurement: Using the SNOT-22 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Sadatnasseri
Kermanshah University of Medical Sciences
Outcome results
None listed